[Medical management of chronic Chlamydia trachomatis salpingitis resistant to usual antibiotics. Use of ofloxacin alone or combined with other anti-chlamydia antibiotics].
Henry-Suchet
J
J
Centre Hospitalier Jean Rostand, Sèvres.
Tannous
W
W
D000328:Adult; D002690:Chlamydia Infections / Q000188:drug therapy* / Q000382:microbiology; D002692:Chlamydia trachomatis; D002908:Chronic Disease; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D015575:Roxithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D012488:Salpingitis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology
D015575:Roxithromycin; D015242:Ofloxacin; D004318:Doxycycline
Prise en charge médicale des salpingites chroniques à Chlamydia trachomatis résistant aux antibiotiques habituels. Intérêts de l'ofloxacine seule ou associée à d'autres antichlamydiens.